You searched for "regenerative"

1513 results found

Efficacy and safety of novel PF brimonidine / timolol fixed-combination ophthalmic solution for OAG

This study is a multicentre, randomised, open-label, parallel-group clinical trial to evaluate the efficacy and safety of a newly developed preservative-free (PF) brimonidine / timolol fixed-combination (BTFC) ophthalmic solutions as compared with preservative-containing (PC) BTFC ophthalmic solution in adult patients...

Strabismus and scleral buckling

The authors examine the incidence of strabismus following scleral buckle for retinal detachment surgery and the factors that influence the strabismus, its incidence, preventative measures and treatment options. This was a retrospective review of 344 patients (360 eyes) with a...

Risk factors for DSEAK graft detachment

This was a retrospective data review on all patients who underwent primary descemet stripping automated endothelial keratoplasty (DSEAK) during a 10 year period: 1212 eyes were included in the analysis. Postoperative graft detachment occurred in 45 eyes (3.7%) and required...

Causes of childhood open globe injuries sustained during playtime

This study explored the possible mechanisms of paediatric open globe injuries that occurred during playtime and required surgical treatment. The study was conducted in a single centre in Egypt. This was a prospective study of all children admitted with open...

My top five: Emerging alternatives to manage and treat nAMD

Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

Maximising the ocular surface prior to cataract surgery: The old and the new modalities of treatment

Cataract surgery is among the most commonly performed surgical procedures worldwide. Over time, it has evolved from a lens-extraction procedure into a refractive intervention that demands meticulous perioperative planning and precision to achieve optimal outcomes. Optimisation of the ocular surface...

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Retina Subspecialty Day highlights from the RCOphth 2026 Annual Congress

Implementation of biosimilars in NHS retinal services A NHS England (NHSE) perspective Luke Nicholson (Moorfields Eye Hospital) explained that the NHSE perspective overall is structured on best value medicine for the patient and system, accounting for a finite budget and...

What's trending Apr/May 2025

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ContactLens #Trapped I started wearing contact lenses in my teenage years and was always worried about them slipping behind my eyes....

Joint statement on improving driver vision standards across the UK

UK road safety is under renewed scrutiny. As the Government prepares its new road safety strategy, we believe now is the time to modernise the UK’s approach to driving vision and make our roads safer for everyone. We welcome and...

Broadening of treatment options for potentially blinding retinal conditions

Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...